| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.35 | 3e-06 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.33 | 1e-05 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.31 | 4e-05 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0003 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.004 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.005 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |